Immunosens Co., Ltd.

Various health data can be easily measured with our original immunoassay method GLEIA By using GLEIA, future life will become a little more vibrant and rich.

Funding reportedLast round: Series B

Medical practiceSuita, Japan

About Immunosens Co., Ltd.

Various health data can be easily measured with our original immunoassay method GLEIA By using GLEIA, future life will become a little more vibrant and rich.

We aim to realize a world where people can live healthy and long lives.

What company datasets say Immunosens Co., Ltd. raised

Funding, as reported

Reported in all315Min the source's currency

Rounds4

Last roundSeries B

Last round dateFeb 2023

Investors listed3

On a portfolio page

Investors who name them

Global Brain Corporation

Each firm lists Immunosens Co., Ltd. on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

The company, in detail

What they build

Known for

medical practiceshospital & health care

Built with from their website

Slack

Sector: Medical practice
Full record: Every detail in the company directory

Medical practice in Japan

Startups like it

Is this your company?

Add your raise, your deck and your story, and put Immunosens Co., Ltd. in front of investors. Or tell us what we have wrong.

List your startup Send a correction